• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用反义寡脱氧核苷酸抑制EWS-FLI-1融合蛋白

Inhibition of EWS-FLI-1 fusion protein with antisense oligodeoxynucleotides.

作者信息

Toretsky J A, Connell Y, Neckers L, Bhat N K

机构信息

Pediatric Branch, National Cancer Institute, Bethesda, MD 20892, USA.

出版信息

J Neurooncol. 1997 Jan;31(1-2):9-16. doi: 10.1023/a:1005716926800.

DOI:10.1023/a:1005716926800
PMID:9049825
Abstract

Ewing's sarcoma family of tumors (EFT) contain reciprocal translocations, of which approximately 90% occur between the long arm of chromosomes 11 and 22,t(11;22)(q24;q12) resulting in the formation of chimeric proteins generated by a fusion of the EWS and FLI-1 genes. To determine if EWS-FLI-1 protein is responsible for the Ewing sarcoma phenotype we have used sequence-specific antisense oligodeoxynucleotides (ODN) to block its expression. We have evaluated a series of antisense ODN directed toward the breakpoint region in an effort to prevent translation of the fusion messenger RNA. ODN were first evaluated in a cell-free in vitro translation system. Exogenously added RNase H was found to be required for translation inhibition. ODN that showed complete inhibition of translation were electroporated into TC-32 cells, a EFT cell line. Fusion protein and EWS protein levels were evaluated by Western blot analysis. A 40-60% decrease in the fusion protein was observed in TC-32 cells with antisense ODN directed toward the breakpoint region. Cell viability was reduced with antisense sequences in TC-32 cells but not in a prostate cancer cell line. Since inhibition of t(11:22) gene product is correlated to effects on cell viability reduction of the fusion protein may thus offer insight into the biology of EFT.

摘要

尤因肉瘤家族性肿瘤(EFT)存在相互易位,其中约90%发生在11号和22号染色体长臂之间,即t(11;22)(q24;q12),导致由EWS和FLI-1基因融合产生嵌合蛋白。为了确定EWS-FLI-1蛋白是否导致尤因肉瘤表型,我们使用序列特异性反义寡脱氧核苷酸(ODN)来阻断其表达。我们评估了一系列针对断点区域的反义ODN,以阻止融合信使核糖核酸的翻译。ODN首先在无细胞体外翻译系统中进行评估。发现外源性添加核糖核酸酶H是抑制翻译所必需的。将显示完全抑制翻译的ODN电穿孔导入EFT细胞系TC-32细胞中。通过蛋白质免疫印迹分析评估融合蛋白和EWS蛋白水平。在导入针对断点区域的反义ODN的TC-32细胞中,观察到融合蛋白减少了40 - 60%。反义序列降低了TC-32细胞的活力,但对前列腺癌细胞系无此作用。由于对t(11:22)基因产物的抑制与对细胞活力的影响相关,融合蛋白的减少可能因此为深入了解EFT的生物学特性提供线索。

相似文献

1
Inhibition of EWS-FLI-1 fusion protein with antisense oligodeoxynucleotides.用反义寡脱氧核苷酸抑制EWS-FLI-1融合蛋白
J Neurooncol. 1997 Jan;31(1-2):9-16. doi: 10.1023/a:1005716926800.
2
NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma.在尤因肉瘤中,EWS/FLI介导的致癌表型需要NR0B1。
Mol Cancer Res. 2006 Nov;4(11):851-9. doi: 10.1158/1541-7786.MCR-06-0090.
3
EWS-FLI-1 expression triggers a Ewing's sarcoma initiation program in primary human mesenchymal stem cells.EWS-FLI-1表达在原代人骨髓间充质干细胞中触发尤因肉瘤起始程序。
Cancer Res. 2008 Apr 1;68(7):2176-85. doi: 10.1158/0008-5472.CAN-07-1761.
4
Variability in gene expression patterns of Ewing tumor cell lines differing in EWS-FLI1 fusion type.EWS-FLI1融合类型不同的尤因肿瘤细胞系基因表达模式的变异性。
Lab Invest. 2000 Dec;80(12):1833-44. doi: 10.1038/labinvest.3780194.
5
A link between basic fibroblast growth factor (bFGF) and EWS/FLI-1 in Ewing's sarcoma cells.尤文肉瘤细胞中碱性成纤维细胞生长因子(bFGF)与EWS/FLI-1之间的联系。
Oncogene. 2000 Aug 31;19(37):4298-301. doi: 10.1038/sj.onc.1203755.
6
Transactivation of cyclin E gene by EWS-Fli1 and antitumor effects of cyclin dependent kinase inhibitor on Ewing's family tumor cells.EWS-Fli1对细胞周期蛋白E基因的反式激活及细胞周期蛋白依赖性激酶抑制剂对尤因家族肿瘤细胞的抗肿瘤作用。
Int J Cancer. 2005 Sep 1;116(3):385-94. doi: 10.1002/ijc.21010.
7
Small interfering RNAs expressed from a Pol III promoter suppress the EWS/Fli-1 transcript in an Ewing sarcoma cell line.由RNA聚合酶III启动子表达的小分子干扰RNA可抑制尤因肉瘤细胞系中的EWS/Fli-1转录本。
Mol Ther. 2003 Jun;7(6):811-6. doi: 10.1016/s1525-0016(03)00101-1.
8
Regulatory role of mevalonate and N-linked glycosylation in proliferation and expression of the EWS/FLI-1 fusion protein in Ewing's sarcoma cells.甲羟戊酸和N-糖基化在尤因肉瘤细胞中EWS/FLI-1融合蛋白增殖及表达中的调控作用
Exp Cell Res. 1999 Jan 10;246(1):38-46. doi: 10.1006/excr.1998.4280.
9
EWS/Fli-1 chimeric fusion gene upregulates vascular endothelial growth factor-A.EWS/Fli-1 嵌合融合基因上调血管内皮生长因子-A。
Int J Cancer. 2010 Jun 15;126(12):2790-8. doi: 10.1002/ijc.24781.
10
An EWS/ERG fusion with a truncated N-terminal domain of EWS in a Ewing's tumor.尤因肉瘤中一种EWS/ERG融合体,其EWS的N端结构域被截断。
Int J Cancer. 1996 Jul 29;67(3):339-42. doi: 10.1002/(SICI)1097-0215(19960729)67:3<339::AID-IJC6>3.0.CO;2-S.

引用本文的文献

1
One oncogene, several vulnerabilities: EWS/FLI targeted therapies for Ewing sarcoma.一个癌基因,多种脆弱性:尤因肉瘤的EWS/FLI靶向疗法
J Bone Oncol. 2021 Dec 1;31:100404. doi: 10.1016/j.jbo.2021.100404. eCollection 2021 Dec.
2
Ewing Sarcoma-Diagnosis, Treatment, Clinical Challenges and Future Perspectives.尤因肉瘤——诊断、治疗、临床挑战与未来展望
J Clin Med. 2021 Apr 14;10(8):1685. doi: 10.3390/jcm10081685.
3
Mithramycin 2'-Oximes with Improved Selectivity, Pharmacokinetics, and Ewing Sarcoma Antitumor Efficacy.米托蒽醌 2'-肟衍生物:改善选择性、药代动力学特性和尤文肉瘤抗肿瘤疗效。

本文引用的文献

1
Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation.尤因肉瘤11号与22号染色体易位产生一种嵌合转录因子,该因子转化需要由FLI1编码的DNA结合结构域。
Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5752-6. doi: 10.1073/pnas.90.12.5752.
2
Investigations of antisense oligonucleotides targeted against bcl-2 RNAs.针对bcl-2 RNA的反义寡核苷酸研究。
Antisense Res Dev. 1993 Summer;3(2):157-69. doi: 10.1089/ard.1993.3.157.
3
Electroporation enhances c-myc antisense oligodeoxynucleotide efficacy.
J Med Chem. 2020 Nov 25;63(22):14067-14086. doi: 10.1021/acs.jmedchem.0c01526. Epub 2020 Nov 16.
4
Pediatric sarcomas display a variable EpCAM expression in a histology-dependent manner.小儿肉瘤以组织学依赖的方式表现出可变的上皮细胞黏附分子(EpCAM)表达。
Transl Oncol. 2020 Nov;13(11):100846. doi: 10.1016/j.tranon.2020.100846. Epub 2020 Aug 14.
5
Exploiting Signaling Pathways and Immune Targets Beyond the Standard of Care for Ewing Sarcoma.探索尤因肉瘤标准治疗方案以外的信号通路和免疫靶点。
Front Oncol. 2019 Jun 19;9:537. doi: 10.3389/fonc.2019.00537. eCollection 2019.
6
USP19 deubiquitinates EWS-FLI1 to regulate Ewing sarcoma growth.USP19 通过去泛素化 EWS-FLI1 来调节尤文肉瘤生长。
Sci Rep. 2019 Jan 30;9(1):951. doi: 10.1038/s41598-018-37264-5.
7
Proteasomal Degradation of the EWS-FLI1 Fusion Protein Is Regulated by a Single Lysine Residue.EWS-FLI1融合蛋白的蛋白酶体降解受单个赖氨酸残基调控。
J Biol Chem. 2016 Dec 23;291(52):26922-26933. doi: 10.1074/jbc.M116.752063. Epub 2016 Nov 8.
8
Recent advances in targeted therapy for Ewing sarcoma.尤因肉瘤靶向治疗的最新进展
F1000Res. 2016 Aug 25;5. doi: 10.12688/f1000research.8631.1. eCollection 2016.
9
Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse model.六个独立实验室尝试创建尤文肉瘤小鼠模型的综合经验。
Oncotarget. 2017 May 23;8(21):34141-34163. doi: 10.18632/oncotarget.9388.
10
Preclinical Justification of pbi-shRNA EWS/FLI1 Lipoplex (LPX) Treatment for Ewing's Sarcoma.pbi-shRNA EWS/FLI1脂质体复合物(LPX)治疗尤因肉瘤的临床前论证
Mol Ther. 2016 Aug;24(8):1412-22. doi: 10.1038/mt.2016.93. Epub 2016 May 11.
电穿孔增强c-myc反义寡脱氧核苷酸的疗效。
Nucleic Acids Res. 1993 Jul 25;21(15):3567-73. doi: 10.1093/nar/21.15.3567.
4
Analysis of the DNA-binding and transcriptional activation functions of human Fli-1 protein.人Fli-1蛋白的DNA结合及转录激活功能分析
Oncogene. 1993 Aug;8(8):2167-73.
5
Genomic structure of the EWS gene and its relationship to EWSR1, a site of tumor-associated chromosome translocation.EWS基因的基因组结构及其与EWSR1的关系,EWSR1是肿瘤相关染色体易位的位点。
Genomics. 1993 Dec;18(3):609-15. doi: 10.1016/s0888-7543(05)80363-5.
6
The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1.尤因肉瘤EWS/FLI-1融合基因编码一种更强效的转录激活因子,并且是一种比FLI-1更强大的转化基因。
Mol Cell Biol. 1993 Dec;13(12):7393-8. doi: 10.1128/mcb.13.12.7393-7398.1993.
7
Suppression of Philadelphia1 leukemia cell growth in mice by BCR-ABL antisense oligodeoxynucleotide.BCR-ABL反义寡脱氧核苷酸对小鼠费城1型白血病细胞生长的抑制作用
Proc Natl Acad Sci U S A. 1994 May 10;91(10):4504-8. doi: 10.1073/pnas.91.10.4504.
8
DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma.尤因肉瘤中因t(11;22)易位产生的EWS-FLI-1融合蛋白的DNA结合及转录激活特性
Mol Cell Biol. 1994 May;14(5):3230-41. doi: 10.1128/mcb.14.5.3230-3241.1994.
9
A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG.另一种尤因肉瘤易位,即t(21;22),将EWS基因与另一种ETS家族转录因子ERG融合。
Nat Genet. 1994 Feb;6(2):146-51. doi: 10.1038/ng0294-146.
10
ERG gene is translocated in an Ewing's sarcoma cell line.ERG基因在一种尤因肉瘤细胞系中发生易位。
Cancer Genet Cytogenet. 1994 Aug;76(1):19-22. doi: 10.1016/0165-4608(94)90063-9.